Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

NMS-P-715 inhibits tumor growth by targeting the mitotic checkpoint

Dec. 7, 2009

Phase I trial reveals promising activity of MGCD-265 in advanced malignancies

Dec. 7, 2009

Aflunov vaccine immunogenic and well tolerated in children and adolescents

Dec. 7, 2009

Epigallocatechin gallate possibly beneficial in open-angle glaucoma patients

Dec. 4, 2009

Novel AR antagonist ZR-291 exhibits potent preclinical activity in prostate cancer

Dec. 4, 2009

Small-molecule compound BRA-101 reduces DSS-induced murine colitis

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

Prasugrel more effective than clopidogrel in CAD patients with type 2 diabetes

Dec. 4, 2009

New camptothecin conjugate evaluated in phase I trial in advanced solid tumors

Dec. 4, 2009

GSK-2126458 shows potent preclinical antitumor activity; phase I trial under way

Dec. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.